Isaura Santos,  —

Isaura Santos graduated with a BS in Cell and Molecular Biology from Universidade Nova de Lisboa and a MA in Communication, Culture and Information Technologies from University Institute of Lisbon (ISCTE-IUL). Her professional interests include science communication, public awareness of science and communication of science through entertainment.

Articles by Isaura Santos

Smart Oxygen Solutions’ Supplemental Oxygen Delivery Device Supasses FDA Regulatory Pathway Milestone

ieCrowd™ recently announced the achievement of a crucial milestone in the commercial advancement of Smart Oxygen, the firm’s supplemental oxygen delivery device. The Smart Oxygen device is being advanced by ieCrowd’s subsidiary Smart Oxygen Solutions and has the ability to automatically adjust to the patient’s need for oxygen, even if those demands are constantly changing, through analyzing the level of…

Entra Health Launches The Entra360 Platform

Entra Health has recently announced the launch of Entra360, a novel solution for easily and effectively implementing wireless biometric data. Entra360 is a particularly innovative solution for both the payer or provider, as well as the COPD clinical research market. Entra360 is one of several efforts the company is making to provide easy-to-implement solutions to allow remote…

Aquinox Pharmaceuticals Updates FLAGSHIP COPD Trial Status

The ACI Association recently compiled a report on Aquinox Pharmaceuticals Inc. based on the company’s internal reports to make them available to the general public. Aquinox is currently developing AQX-1125, an investigational therapy for COPD, which was recently evaluated in a phase 2 clinical trial called FLAGSHIP. Aquinox announced recently that its FLAGSHIP…

Quintiles To Host 2015 SMi Conference on Improving COPD Clinical Trials

After several successful events covering respiratory disease research and drug development, SMi’s conference on COPD will be held again this year in Central London. Now in its seventh consecutive year, SMi’s COPD conference is scheduled for the 19th and 20th October. Sponsored by Quintiles, a leading biotech CRO, this year’s conference will feature an exclusive post-conference event as…

Traditional Chinese Exercises Might Assist COPD Patients

COPD is a major global public heath issue. According to a study in the Lancet, 329 million people have COPD worldwide, which accounts for nearly 5% of the world’s population. In 2013 alone, 2.9 million people died from the disease throughout the world, up from 2.4 million deaths…

New Study Confirms Half of COPD Patients’ Disease Develops Slowly

Chronic obstructive pulmonary disease (COPD) is one of the most frequent causes of death worldwide and active smoking is responsible for almost 85 percent of all cases. However, recent research from the University of Copenhagen shows that accelerated decline of lung function might not be a prerequisite for COPD. The results were recently published in the New England…

First COPD Biomarker Approved By FDA

The COPD Foundation has announced that plasma fibrinogen, a new clinical biomarker, was approved to be used in interventional clinical trials for those suffering with chronic obstructive pulmonary disease (COPD), the number 3 cause of death in the country. This is the first biomarker for COPD to receive qualification from the United States Food…

Imaging Might Improve Treatment Of COPD Patients

Computed tomography (CT) and magnetic resonance imaging (MRI) provide relevant information about the symptoms and exercise capabilities of those suffering with mild-to-moderate chronic obstructive pulmonary disease (COPD), a finding that was recently published in the Radiology journal that could lead to new and better treatments for COPD patients. COPD, a progressive disease of the…